Market News

Hudson Valley Investment Advisors Has Boosted Celgene (CELG) Holding; British American Tobacco p.l.c. (LON:BATS) Had 15 Bulls

Celgene Corporation (NASDAQ:CELG) Logo

Among 23 analysts covering British American Tobacco PLC (LON:BATS), 15 have Buy rating, 3 Sell and 5 Hold. Therefore 65% are positive. British American Tobacco PLC had 263 analyst reports since July 24, 2015 according to SRatingsIntel. As per Wednesday, October 7, the company rating was maintained by Deutsche Bank. The stock of British American Tobacco p.l.c. (LON:BATS) earned “Overweight” rating by JP Morgan on Wednesday, August 24. Barclays Capital maintained British American Tobacco p.l.c. (LON:BATS) on Thursday, February 25 with “Overweight” rating. Credit Suisse maintained British American Tobacco p.l.c. (LON:BATS) rating on Wednesday, July 29. Credit Suisse has “Outperform” rating and GBX 3800 target. Credit Suisse maintained the stock with “Outperform” rating in Friday, February 24 report. The firm has “Buy” rating by Beaufort Securities given on Wednesday, October 26. The rating was maintained by Deutsche Bank with “Buy” on Thursday, July 30. The firm has “Overweight” rating by Morgan Stanley given on Wednesday, March 28. The firm earned “Outperform” rating on Thursday, June 29 by Credit Suisse. The firm earned “Sell” rating on Thursday, February 25 by Canaccord Genuity. See British American Tobacco p.l.c. (LON:BATS) latest ratings:

28/03/2018 Broker: Credit Suisse Rating: Outperform Old Target: GBX 5800.00 New Target: GBX 5800.00 Maintain
28/03/2018 Broker: Morgan Stanley Rating: Overweight Maintain
23/03/2018 Broker: Morgan Stanley Rating: Overweight Old Target: GBX 5500.00 New Target: GBX 5500.00 Maintain
12/03/2018 Broker: Jefferies Rating: Buy Old Target: GBX 5800.00 New Target: GBX 6000.00 Maintain
05/03/2018 Broker: Goldman Sachs Rating: Buy Old Target: GBX 5850.00 New Target: GBX 5400.00 Maintain
28/02/2018 Broker: JP Morgan Rating: Overweight Old Target: GBX 5610.00 New Target: GBX 5185.00 Maintain
26/02/2018 Broker: Berenberg Rating: Buy Old Target: GBX 5720.00 New Target: GBX 5340.00 Reiteration
23/02/2018 Broker: JP Morgan Rating: Overweight Old Target: GBX 5610.00 New Target: GBX 5610.00 Maintain
23/02/2018 Broker: Morgan Stanley Rating: Overweight Old Target: GBX 6000.00 New Target: GBX 5500.00 Maintain
23/02/2018 Broker: Citigroup Rating: Buy New Target: GBX 6000.00 Maintain

Hudson Valley Investment Advisors Inc increased Celgene Corp (CELG) stake by 17.34% reported in 2017Q4 SEC filing. Hudson Valley Investment Advisors Inc acquired 4,088 shares as Celgene Corp (CELG)’s stock declined 19.30%. The Hudson Valley Investment Advisors Inc holds 27,659 shares with $2.89M value, up from 23,571 last quarter. Celgene Corp now has $67.31B valuation. The stock increased 0.60% or $0.535 during the last trading session, reaching $89.485. About 3.47 million shares traded. Celgene Corporation (NASDAQ:CELG) has declined 31.28% since April 24, 2017 and is downtrending. It has underperformed by 42.83% the S&P500.

Since February 8, 2018, it had 1 buying transaction, and 3 sales for $3.58 million activity. Shares for $299,594 were bought by Alles Mark J. $1.77M worth of stock was sold by KAPLAN GILLA on Thursday, February 15. 9,250 shares were sold by LOUGHLIN JAMES J, worth $851,093. 13,370 shares valued at $1.26M were sold by MARIO ERNEST on Friday, February 23.

Investors sentiment decreased to 0.83 in Q4 2017. Its down 0.34, from 1.17 in 2017Q3. It worsened, as 156 investors sold CELG shares while 478 reduced holdings. 118 funds opened positions while 411 raised stakes. 561.38 million shares or 7.06% less from 603.99 million shares in 2017Q3 were reported. Burns J W And Communication Inc New York, a New York-based fund reported 47,748 shares. Beacon Financial Grp Inc has invested 0.04% in Celgene Corporation (NASDAQ:CELG). Sandy Spring National Bank & Trust has 39,360 shares. Edge Wealth Management Limited Liability Co accumulated 0.48% or 16,113 shares. Mitsubishi Ufj Holdings Ltd invested 0.48% in Celgene Corporation (NASDAQ:CELG). Tocqueville Asset Mgmt LP has invested 0.13% of its portfolio in Celgene Corporation (NASDAQ:CELG). Sigma Investment Counselors has invested 0.4% in Celgene Corporation (NASDAQ:CELG). Alpine Woods Invsts Ltd invested in 0.04% or 8,500 shares. Everett Harris And Ca reported 4,120 shares stake. Grp Incorporated One Trading LP invested 0.09% in Celgene Corporation (NASDAQ:CELG). The Washington-based Saturna Capital has invested 0.68% in Celgene Corporation (NASDAQ:CELG). Beck Mack And Oliver Ltd Com has 0.02% invested in Celgene Corporation (NASDAQ:CELG). Messner And Smith Theme Value Investment Mngmt Ca reported 10,516 shares stake. Benjamin F Edwards & owns 0.07% invested in Celgene Corporation (NASDAQ:CELG) for 6,249 shares. Enterprise Financial Services Corp has invested 0.18% in Celgene Corporation (NASDAQ:CELG).

Among 34 analysts covering Celgene Corporation (NASDAQ:CELG), 19 have Buy rating, 1 Sell and 14 Hold. Therefore 56% are positive. Celgene Corporation has $190 highest and $83 lowest target. $129.76’s average target is 45.01% above currents $89.485 stock price. Celgene Corporation had 142 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Neutral” rating by BTIG Research given on Friday, June 30. Canaccord Genuity maintained Celgene Corporation (NASDAQ:CELG) rating on Monday, October 16. Canaccord Genuity has “Buy” rating and $156.0 target. The stock of Celgene Corporation (NASDAQ:CELG) earned “Buy” rating by Stifel Nicolaus on Friday, July 15. Cantor Fitzgerald maintained the shares of CELG in report on Thursday, July 6 with “Buy” rating. The firm has “Buy” rating by Leerink Swann given on Friday, October 20. The firm has “Buy” rating given on Monday, January 8 by SunTrust. Oppenheimer maintained it with “Outperform” rating and $166 target in Monday, October 30 report. The stock of Celgene Corporation (NASDAQ:CELG) has “Buy” rating given on Friday, July 24 by UBS. BMO Capital Markets maintained Celgene Corporation (NASDAQ:CELG) rating on Friday, October 27. BMO Capital Markets has “Outperform” rating and $148 target. The rating was maintained by BMO Capital Markets on Friday, November 17 with “Outperform”.

British American Tobacco p.l.c. engages in the production and sale of tobacco products. The company has market cap of 80.04 billion GBP. It provides cigarettes and cigars; snus, a low-toxicant smokeless tobacco product; and e-cigarettes and other products, such as vapor and tobacco heating products, as well as nicotine inhalers. It has a 2.06 P/E ratio. The firm offers its products under the Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Vogue, Viceroy, Kool, Peter Stuyvesant, Craven A, Benson & Hedges, John Player Gold Leaf, State Express 555, and Shuang Xi brands.

The stock increased 0.36% or GBX 13.5 during the last trading session, reaching GBX 3768. About 737,643 shares traded. British American Tobacco p.l.c. (LON:BATS) has 0.00% since April 24, 2017 and is . It has underperformed by 11.55% the S&P500.

Celgene Corporation (NASDAQ:CELG) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *